| Alterations in cholesterol metabolism as a risk factor for developing Alzheimer’s disease: Potential novel targets for treatment R Loera-Valencia, J Goikolea, C Parrado-Fernandez, P Merino-Serrais, ... The Journal of steroid biochemistry and molecular biology 190, 104-114, 2019 | 136 | 2019 |
| Current and emerging avenues for Alzheimer's disease drug targets R Loera‐Valencia, A Cedazo‐Minguez, PA Kenigsberg, G Page, ... Journal of internal medicine 286 (4), 398-437, 2019 | 102 | 2019 |
| Targeting Alzheimer's disease with gene and cell therapies R Loera‐Valencia, A Piras, MAM Ismail, S Manchanda, H Eyjolfsdottir, ... Journal of Internal Medicine 284 (1), 2-36, 2018 | 48 | 2018 |
| 27-Hydroxycholesterol induces aberrant morphology and synaptic dysfunction in hippocampal neurons P Merino-Serrais, R Loera-Valencia, P Rodriguez-Rodriguez, ... Cerebral cortex 29 (1), 429-446, 2019 | 43 | 2019 |
| Connecting the brain cholesterol and renin–angiotensin systems: potential role of statins and RAS‐modifying medications in dementia B Petek, M Villa‐Lopez, R Loera‐Valencia, G Gerenu, B Winblad, ... Journal of internal medicine 284 (6), 620-642, 2018 | 25 | 2018 |
| Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the AppNL-G-F mouse model of Alzheimer’s disease LE Arroyo-García, AG Isla, Y Andrade-Talavera, H Balleza-Tapia, ... Molecular Psychiatry 26 (10), 5557-5567, 2021 | 21 | 2021 |
| Brain renin–angiotensin system as novel and potential therapeutic target for Alzheimer’s disease R Loera-Valencia, F Eroli, S Garcia-Ptacek, S Maioli International Journal of Molecular Sciences 22 (18), 10139, 2021 | 20 | 2021 |
| Ano1 is a better marker than c-Kit for transcript analysis of single interstitial cells of Cajal in culture R Loera-Valencia, XY Wang, GWJ Wright, C Barajas-López, JD Huizinga Cellular & Molecular Biology Letters 19, 601-610, 2014 | 17 | 2014 |
| Hypercholesterolemia and 27-hydroxycholesterol increase S100A8 and rage expression in the brain: A link between cholesterol, alarmins, and neurodegeneration R Loera-Valencia, MAM Ismail, J Goikolea, M Lodeiro, L Mateos, ... Molecular Neurobiology 58 (12), 6063-6076, 2021 | 11 | 2021 |
| High levels of 27-hydroxycholesterol results in synaptic plasticity alterations in the hippocampus R Loera-Valencia, E Vazquez-Juarez, A Muñoz, G Gerenu, ... Scientific Reports 11 (1), 1-13, 2021 | 11 | 2021 |
| Cholinergic signalling-regulated KV7.5 currents are expressed in colonic ICC-IM but not ICC-MP GWJ Wright, SP Parsons, R Loera-Valencia, XY Wang, C Barajas-López, ... Pflügers Archiv-European Journal of Physiology 466, 1805-1818, 2014 | 11 | 2014 |
| Thioredoxin-80 protects against amyloid-beta pathology through autophagic-lysosomal pathway regulation G Gerenu, T Persson, J Goikolea, J Calvo-Garrido, R Loera-Valencia, ... Molecular Psychiatry 26 (4), 1410-1423, 2021 | 9 | 2021 |
| Expression of P2X3 and P2X5 Myenteric Receptors Varies During the Intestinal Postnatal Development in the Guinea Pig R Loera-Valencia, NN Jiménez-Vargas, EC Villalobos, EH Juárez, ... Cellular and molecular neurobiology 34, 727-736, 2014 | 7 | 2014 |
| Defects of nutrient signaling and autophagy in neurodegeneration J Ondaro, H Hernandez-Eguiazu, M Garciandia-Arcelus, ... Frontiers in Cell and Developmental Biology 10, 517, 2022 | 5 | 2022 |
| Development of zinc oxide/hydroxyapatite/poly (D, L-lactic acid) fibrous scaffold for tissue engineering applications V Padilla-Gainza, H Rodríguez-Tobías, G Morales, A Ledezma-Pérez, ... Biomaterials Advances 133, 112594, 2022 | 5 | 2022 |
| Somatostatin receptor subtypes 1 and 4 redundantly regulate neprilysin, the major amyloid-beta degrading enzyme in brain P Nilsson, K Sörgjerd, N Kakiya, H Sasaguri, N Watamura, M Shimozawa, ... bioRxiv, 2020.05. 09.085795, 2020 | 5 | 2020 |
| Restoring synaptic function through multimodal therapeutics R Loera-Valencia, P Nilsson, B Winblad Progress in Molecular Biology and Translational Science 168, 257-275, 2019 | 5 | 2019 |
| Evaluation of the therapeutic efficacy of dressings with ZnO nanoparticles in the treatment of diabetic foot ulcers R Loera-Valencia, RE Neira, BP Urbina, A Camacho, RB Galindo Biomedicine & Pharmacotherapy 155, 113708, 2022 | 2 | 2022 |
| Genomic organization of purinergic P2X receptors R Loera Valencia, JO Jaramillo Polanco, A Liñan Rico, ... | 2 | 2015 |
| Neuron-derived Thioredoxin-80: a novel regulator of type-I interferon response in microglia J Goikolea, JP Roussarie, G Gerenu, R Loera-Valencia, M Latorre-Leal, ... bioRxiv, 2022.03. 09.483648, 2022 | | 2022 |
Angel Cedazo-MinguezKarolinska Institutet (Sweden)Verified email at ki.se
